According to the ministry, 85 pharmaceutical companies have reported revised MRPs for 1,364 anti-cancer formulations across 121 drugs as of November 8, 2026. Consumers are set to save an estimated Rs 3,540.38 crore annually following the implementation of revised Maximum Retail Prices (MRPs) of 1,364 anti-cancer formulations from Monday, according to. Revised MRPs for 1,364 anti-cancer formulations save consumers about ₹3,540 crore annually, with price caps and verification via NPPA.